Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Talib Dosani, Fahrettin Covut, Raisa Pinto, Byung-Gyu Kim, Naveed Ali, Rose Beck, Robert Maitta, Katharine Downes, Robert Fox, Jane Reese, Marcos de Lima & Ehsan Malek. (2019) Impact of lenalidomide on collected hematopoietic myeloid and erythroid progenitors: peripheral stem cell collection may not be affected. Leukemia & Lymphoma 60:9, pages 2199-2206.
Read now
Read now
Natalia Tovar, Luis Gerardo Rodríguez-Lobato, Maria Teresa Cibeira, Laura Magnano, Ignacio Isola, Laura Rosiñol, Joan Bladé & Carlos Fernández de Larrea. (2018) Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome. Amyloid 25:2, pages 79-85.
Read now
Read now
Elisabet E. Manasanch. (2017) Pre-transplant bone marrow myeloma cells: less is better. Leukemia & Lymphoma 58:2, pages 253-254.
Read now
Read now
Articles from other publishers (12)
Cristina João, Rui Bergantim, Joana Santos, Celina Afonso, Paulo Bernardo, Henrique Coelho, Carlos Costa, Graça Esteves, José Guilherme Freitas, Rita Gerivaz, Ana Jorge, Ana Macedo, Ana Montalvão, Manuel Neves, Claúdia L. Pedrosa, Susana Pereira, Adriana Roque, Patrícia Seabra, Helena M. Silva, Maria P. Silveira, Ana Tomé, Fernanda Trigo, Ana Bela Sarmento, Paulo Lúcio, Catarina Geraldes & Em representação do GRUPO PORTUGUÊS DO MIELOMA MÚLTIPLO. (2023) Recomendações do Grupo Português do Mieloma Múltiplo para Tratamento do Mieloma Múltiplo. Acta Médica Portuguesa 36:7-8, pages 517-526.
Crossref
Crossref
Tünde Tóth, Hussain Alizadeh, Beáta Polgár, Renáta Csalódi, Dóra Reglődi & Andrea Tamás. (2023) Diagnostic and Prognostic Value of PACAP in Multiple Myeloma. International Journal of Molecular Sciences 24:13, pages 10801.
Crossref
Crossref
Rahul Banerjee, Louis Williams & Joseph R. Mikhael. (2023) Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma. Blood Cancer Journal 13:1.
Crossref
Crossref
Markus Wennmann, Wenlong Ming, Fabian Bauer, Jiri Chmelik, André Klein, Charlotte Uhlenbrock, Martin Grözinger, Kim-Celine Kahl, Tobias Nonnenmacher, Manuel Debic, Thomas Hielscher, Heidi Thierjung, Lukas T. Rotkopf, Nikolas Stanczyk, Sandra Sauer, Anna Jauch, Michael Götz, Felix T. Kurz, Kai Schlamp, Marius Horger, Saif Afat, Britta Besemer, Martin Hoffmann, Johannes Hoffend, Doris Kraemer, Ullrich Graeven, Adrian Ringelstein, David Bonekamp, Jens Kleesiek, Ralf O. Floca, Jens Hillengass, Elias K. Mai, Niels Weinhold, Tim F. Weber, Hartmut Goldschmidt, Heinz-Peter Schlemmer, Klaus Maier-Hein, Stefan Delorme & Peter Neher. (2023) Prediction of Bone Marrow Biopsy Results From MRI in Multiple Myeloma Patients Using Deep Learning and Radiomics. Investigative Radiology Publish Ahead of Print.
Crossref
Crossref
Binod Dhakal, Anita D’Souza, Natalie Callander, Saurabh Chhabra, Raphael Fraser, Omar Davila, Kenneth Anderson, Amer Assal, Sherif M. Badawy, Jesus Berdeja, Jan Cerny, Raymond Comenzo, Rajshekhar Chakraborty, Robert Peter Gale, Rammurti Kamble, Mohamed A. Kharfan‐Dabaja, Maxwell Krem, Siddhartha Ganguly, Murali Janakiram, Ankit Kansagra, Reinhold Munker, Hemant Murthy, Sagar Patel, Shaji Kumar, Nina Shah, Muzaffar Qazilbash & Parameswaran Hari. (2020) Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma. British Journal of Haematology 191:3, pages 442-452.
Crossref
Crossref
Andrew J. Cowan, Damian J. Green, Mehdi Karami, Pamela S. Becker, Sherilyn Tuazon, David G. Coffey, Teresa S. Hyun, Edward N. Libby, Ajay K. Gopal & Leona A. Holmberg. (2020) KRD-PACE Mobilization for Multiple Myeloma Patients With Significant Residual Disease Before Autologous Stem-Cell Transplantation. Clinical Lymphoma Myeloma and Leukemia 20:9, pages 602-609.
Crossref
Crossref
Ricardo D. Parrondo, Sikander Ailawadhi, Taimur Sher, Asher A. Chanan-Khan & Vivek Roy. (2020) Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Therapies. JCO Oncology Practice 16:2, pages 56-66.
Crossref
Crossref
Rafiye Ciftciler, Hakan Goker, Yahya Buyukasık, Elifcan Aladag, Emine Arzu Saglam & Haluk Demiroglu. (2019) Impact of bone marrow plasma cells percentage on survival at diagnosis and pre-transplant period in newly diagnosed multiple myeloma: Experience of a single center from Turkey. Transfusion and Apheresis Science 58:3, pages 313-317.
Crossref
Crossref
Wilson I. Gonsalves, Francis K. Buadi, Sikander Ailawadhi, P. Leif Bergsagel, Asher A. Chanan Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Susan R. Hayman, Prashant Kapoor, Taxiarchis V. Kourelis, Martha Q. Lacy, Jeremy T. Larsen, Eli Muchtar, Craig B. Reeder, Taimur Sher, A. Keith Stewart, Rahma Warsame, Ronald S. Go, Robert A. Kyle, Nelson Leung, Yi Lin, John A. Lust, Stephen J. Russell, Stephen R. Zeldenrust, Amie L. Fonder, Yi L. Hwa, Miriam A. Hobbs, Angela A. Mayo, William J. Hogan, S. Vincent Rajkumar, Shaji K. Kumar, Morie A. Gertz & Vivek Roy. (2018) Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement. Bone Marrow Transplantation 54:3, pages 353-367.
Crossref
Crossref
Thomas Dejoie, Jill Corre, Helene Caillon, Philippe Moreau, Michel Attal & Hervé Avet Loiseau. (2018) Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurements. Leukemia 33:2, pages 313-318.
Crossref
Crossref
R Chakraborty, E Muchtar, S K Kumar, F K Buadi, D Dingli, A Dispenzieri, S R Hayman, W J Hogan, P Kapoor, M Q Lacy, N Leung & M A Gertz. (2017) Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation. Bone Marrow Transplantation 53:2, pages 155-161.
Crossref
Crossref
R Chakraborty, E Muchtar, S K Kumar, D Jevremovic, F K Buadi, D Dingli, A Dispenzieri, S R Hayman, W J Hogan, P Kapoor, M Q Lacy, N Leung & M A Gertz. (2016) Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era. Blood Cancer Journal 6:12, pages e512-e512.
Crossref
Crossref